Cocrystal Pharma, Inc. (COCP)
NASDAQ: COCP · IEX Real-Time Price · USD
2.350
0.00 (0.00%)
At close: Jul 19, 2024, 4:00 PM
2.320
-0.030 (-1.28%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
Cocrystal Pharma Market Cap
Cocrystal Pharma has a market cap or net worth of $23.91 million as of July 22, 2024. Its market cap has decreased by -2.01% in one year.
Market Cap
23.91M
Enterprise Value
3.77M
1-Year Change
-2.01%
Ranking
Category
Stock Price
$2.35
Market Cap Chart
Since March 12, 2018, Cocrystal Pharma's market cap has decreased from $115.30M to $23.91M, a decrease of -79.26%. That is a compound annual growth rate of -21.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 23.90M | 36.57% |
| Dec 29, 2023 | 17.50M | 10.06% |
| Dec 30, 2022 | 15.90M | -74.92% |
| Dec 31, 2021 | 63.40M | -31.97% |
| Dec 31, 2020 | 93.20M | 435.63% |
| Dec 31, 2019 | 17.40M | -83.84% |
| Dec 31, 2018 | 107.70M | -6.59% |
| Mar 12, 2018 | 115.30M | - |
View and export this data all the way back to 2018.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Trinity Biotech | 24.42M |
| Unity Biotechnology | 24.34M |
| CytoMed Therapeutics | 24.24M |
| Femasys | 24.22M |
| Akso Health Group | 24.01M |
| NeuroOne Medical Technologies | 23.89M |
| Can-Fite BioPharma | 23.82M |
| Biora Therapeutics | 23.72M |